US EditionShockwave begins study of IVL catheter for coronary artery lesions
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Shockwave begins study of IVL catheter for coronary artery lesions
Shockwave Medical has commenced the IDE study of the Javelin Coronary IVL Catheter for treating calcified coronary lesions.The post Shockwave begins study of IVL catheter for coronary artery lesions appeared first on Medical Device Network.
Shockwave commences trial of Javelin IVL catheter in complex coronary disease - Cardiovascular News
Javelin IVL catheter Shockwave Medical, part of Johnson & Johnson MedTech, has initiated its pivotal FORWARD CAD investigational device exemption (IDE) study, assessing the safety and effectiveness of the Shockwave Javelin coronary intravascular lithotripsy (IVL) catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting. The first patient was treated recently by operators Evan Shlofmit…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
